Infantile Krabbe disease (0-12 months), progression, and recommended endpoints for clinical trials.

Greco MR, Lopez MA, Beltran-Quintero ML, Tuc Bengur E, Poe MD, Escolar ML

Open source

DOI
10.1002/acn3.52114
Published
2024 Dec
Container
Annals of clinical and translational neurology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/acn3.52114,
  title = {Infantile Krabbe disease (0-12 months), progression, and recommended endpoints for clinical trials.},
  author = {Greco MR and Lopez MA and Beltran-Quintero ML and Tuc Bengur E and Poe MD and Escolar ML},
  year = {2024},
  journal = {Annals of clinical and translational neurology},
  doi = {10.1002/acn3.52114},
  url = {https://doi.org/10.1002/acn3.52114}
}

RIS

TY  - JOUR
TI  - Infantile Krabbe disease (0-12 months), progression, and recommended endpoints for clinical trials.
AU  - Greco MR
AU  - Lopez MA
AU  - Beltran-Quintero ML
AU  - Tuc Bengur E
AU  - Poe MD
AU  - Escolar ML
PY  - 2024
JO  - Annals of clinical and translational neurology
DO  - 10.1002/acn3.52114
UR  - https://doi.org/10.1002/acn3.52114
ER  - 

APA

MR, G., MA, L., ML, B., E, T. B., MD, P., & ML, E. (2024). Infantile Krabbe disease (0-12 months), progression, and recommended endpoints for clinical trials.. Annals of clinical and translational neurology. https://doi.org/10.1002/acn3.52114

Source records